Page last updated: 2024-10-20

selenic acid and Liver Cirrhosis

selenic acid has been researched along with Liver Cirrhosis in 1 studies

Selenic Acid: A strong dibasic acid with the molecular formula H2SeO4. Included under this heading is the acid form, and inorganic salts of dihydrogen selenium tetraoxide.

Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burk, RF1
Hill, KE1
Motley, AK1
Byrne, DW1
Norsworthy, BK1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Selenium Supplementation of Patients With Cirrhosis[NCT00271245]99 participants (Actual)Interventional2006-02-28Terminated (stopped due to Insufficient funds to complete study.)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for selenic acid and Liver Cirrhosis

ArticleYear
Selenium deficiency occurs in some patients with moderate-to-severe cirrhosis and can be corrected by administration of selenate but not selenomethionine: a randomized controlled trial.
    The American journal of clinical nutrition, 2015, Volume: 102, Issue:5

    Topics: Adult; Biomarkers; Deficiency Diseases; Dietary Supplements; Female; Glutathione Peroxidase; Humans;

2015